- Home
- VRDN vs LIME Comparison
VRDN vs LIME Comparison
Compare VRDN & LIME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRDN | LIME |
|---|---|---|
| Founded | 2006 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.8B |
| IPO Year | 2014 | 2026 |
Fundamental Metrics
Financial Performance| Metric | VRDN | LIME |
|---|---|---|
| Price | $24.57 | $23.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 17 | 8 |
| Target Price | $36.20 | ★ $37.71 |
| AVG Volume (30 Days) | ★ 2.0M | 301.1K |
| Earning Date | 11-04-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 5.47 |
| Revenue | ★ $5,706,000.00 | N/A |
| Revenue This Year | N/A | $20.91 |
| Revenue Next Year | $878.45 | $15.16 |
| P/E Ratio | ★ N/A | $4.50 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.18 | $22.07 |
| 52 Week High | $34.29 | $44.38 |
Technical Indicators
Market Signals| Indicator | VRDN | LIME |
|---|---|---|
| Relative Strength Index (RSI) | 68.17 | 33.78 |
| Support Level | $21.40 | N/A |
| Resistance Level | $24.86 | $27.16 |
| Average True Range (ATR) | 1.00 | 2.00 |
| MACD | 0.57 | -0.12 |
| Stochastic Oscillator | 88.72 | 10.45 |
Price Performance
Historical ComparisonAbout VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.
About LIME Neutron Holdings Inc. Common Stock
Neutron Holdings Inc is a micromobility company that provides rentals of shared electric scooters (e-scooters) and electric bicycles (e-bikes) through its platform (the Rider App) to be used for short distances in various cities and municipalities around the world.